You are here

  • Home
  • Archive
  • Volume 6, Issue 10
  • Safety and immunogenicity of a new 13-valent pneumococcal conjugate vaccine versus a licensed 7-valent pneumococcal conjugate vaccine: a study protocol of a randomised non-inferiority trial in China

Article metrics

Article menu

Download PDFPDF

XML
Immunology (including allergy)
Protocol
Safety and immunogenicity of a new 13-valent pneumococcal conjugate vaccine versus a licensed 7-valent pneumococcal conjugate vaccine: a study protocol of a randomised non-inferiority trial in China

 

Online download statistics by month:

Online download statistics by month: January 2018 to May 2023

AbstractFullPdf
Jan 2018434315
Feb 2018444421
Mar 2018666716
Apr 2018363615
May 2018505412
Jun 201837374
Jul 2018383814
Aug 201836366
Sep 2018303013
Oct 201820203
Nov 201840407
Dec 2018353518
Jan 2019403917
Feb 2019272714
Mar 2019292610
Apr 2019201812
May 2019181812
Jun 2019151513
Jul 2019313113
Aug 201913136
Oct 2019232214
Nov 2019171721
Dec 2019272513
Jan 2020282518
Feb 2020211920
Mar 2020343313
May 202016169
Jun 202013117
Jul 2020997
Aug 2020171510
Sep 202032247
Oct 202031309
Nov 2020211714
Dec 202012115
Jan 202115138
Feb 202116165
Mar 202117177
Apr 202113146
May 202113135
Jun 2021996
Jul 202116166
Aug 2021181714
Sep 2021161612
Oct 2021161620
Nov 2021242420
Dec 202119197
Jan 2022131312
Feb 202211115
Mar 2022191913
Apr 2022131310
May 2022171716
Jun 2022222110
Jul 202219195
Aug 2022303017
Sep 2022151624
Oct 2022996
Nov 2022151511
Dec 202212116
Jan 2023162113
Feb 2023994
Mar 2023242418
Apr 2023252613
May 2023121110
Total14421416717